Literature DB >> 12911759

Connexin30-deficient mice show increased emotionality and decreased rearing activity in the open-field along with neurochemical changes.

E Dere1, M A De Souza-Silva, C Frisch, B Teubner, G Söhl, K Willecke, J P Huston.   

Abstract

Gap-junction channels in the brain, formed by connexin (Cx) proteins with a distinct regional/cell-type distribution, allow intercellular electrical and metabolic communication. In astrocytes, mainly the connexins 43, 26 and 30 are expressed. In addition, connexin30 is expressed in ependymal and leptomeningeal cells, as well as in skin and cochlea. The functional implications of the astrocytic gap-junctional network are not well understood and evidence regarding their behavioural relevance is lacking. Thus, we have tested groups of Cx30-/-, Cx30+/-, and Cx30+/+ mice in the open-field, an object exploration task, in the graded anxiety test and on the rotarod. The Cx30-/- mice showed reduced exploratory activity in terms of rearings but not locomotion in the open-field and object exploration task. Furthermore, Cx30-/- mice exhibited anxiogenic behaviour as shown by higher open-field centre avoidance and corner preference. Graded anxiety test and rotarod performance was similar across groups. The Cx30-/- mice had elevated choline levels in the ventral striatum, possibly related to their aberrant behavioural phenotypes. The Cx30+/- mice had lower dopamine and metabolite levels in the amygdala and ventral striatum and lower hippocampal 5-hydroxyindole acid (5-HIAA) concentrations relative to Cx30+/+ mice. Furthermore, the Cx30+/- mice had lower acetylcholine concentrations in the ventral striatum and higher choline levels in the neostriatum, relative to Cx30+/+ mice. Our data suggest that the elimination of connexin30 can alter the reactivity to novel environments, pointing to the importance of gap-junctional signalling in behavioural processes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12911759     DOI: 10.1046/j.1460-9568.2003.02784.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  35 in total

Review 1.  Brain connexins in demyelinating diseases: therapeutic potential of glial targets.

Authors:  Maria Luisa Cotrina; Maiken Nedergaard
Journal:  Brain Res       Date:  2012-07-10       Impact factor: 3.252

2.  Connexin-47 and connexin-32 in gap junctions of oligodendrocyte somata, myelin sheaths, paranodal loops and Schmidt-Lanterman incisures: implications for ionic homeostasis and potassium siphoning.

Authors:  N Kamasawa; A Sik; M Morita; T Yasumura; K G V Davidson; J I Nagy; J E Rash
Journal:  Neuroscience       Date:  2005-10-03       Impact factor: 3.590

Review 3.  The molecular bases of the suicidal brain.

Authors:  Gustavo Turecki
Journal:  Nat Rev Neurosci       Date:  2014-10-30       Impact factor: 34.870

4.  Astroglial connexin 43 sustains glutamatergic synaptic efficacy.

Authors:  Oana Chever; Ulrike Pannasch; Pascal Ezan; Nathalie Rouach
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-10-19       Impact factor: 6.237

Review 5.  Gap junctions in inherited human disorders of the central nervous system.

Authors:  Charles K Abrams; Steven S Scherer
Journal:  Biochim Biophys Acta       Date:  2011-08-16

Review 6.  Oligodendroglia: metabolic supporters of neurons.

Authors:  Thomas Philips; Jeffrey D Rothstein
Journal:  J Clin Invest       Date:  2017-09-01       Impact factor: 14.808

7.  Connexin 30 sets synaptic strength by controlling astroglial synapse invasion.

Authors:  Ulrike Pannasch; Dominik Freche; Glenn Dallérac; Grégory Ghézali; Carole Escartin; Pascal Ezan; Martine Cohen-Salmon; Karim Benchenane; Veronica Abudara; Amandine Dufour; Joachim H R Lübke; Nicole Déglon; Graham Knott; David Holcman; Nathalie Rouach
Journal:  Nat Neurosci       Date:  2014-03-02       Impact factor: 24.884

8.  Methamphetamine compromises gap junctional communication in astrocytes and neurons.

Authors:  Paul Castellano; Chisom Nwagbo; Luis R Martinez; Eliseo A Eugenin
Journal:  J Neurochem       Date:  2016-04-18       Impact factor: 5.372

9.  Ablation of neuronal ceramide synthase 1 in mice decreases ganglioside levels and expression of myelin-associated glycoprotein in oligodendrocytes.

Authors:  Christina Ginkel; Dieter Hartmann; Katharina vom Dorp; Armin Zlomuzica; Hany Farwanah; Matthias Eckhardt; Roger Sandhoff; Joachim Degen; Mariona Rabionet; Ekrem Dere; Peter Dörmann; Konrad Sandhoff; Klaus Willecke
Journal:  J Biol Chem       Date:  2012-10-16       Impact factor: 5.157

10.  Deletion of astrocyte connexins 43 and 30 leads to a dysmyelinating phenotype and hippocampal CA1 vacuolation.

Authors:  Sarah E Lutz; Yongmei Zhao; Maria Gulinello; Sunhee C Lee; Cedric S Raine; Celia F Brosnan
Journal:  J Neurosci       Date:  2009-06-17       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.